| Application no. and date | 01905436.0 (espacenet) (Federated) (European Patent Register), 20010205 | | Patent/reg. no. and date | DK/EP 1253932, 20050427 | | Publication date | 20021106 | | Priority no. and date | US 500147, 20000208 | | EP pub. no. and date |
EP 1253932 20021106 | | Effective date | | | Applicant/owner | Allergan, Inc., 2525 Dupont Drive,
Irvine, CA 92612, US | | Applicant ref. no. | 122366 | | Inventor | HUNT, Terrence, J., 5815 E. La Palma, 302
Anaheim Hills, CA 92807, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 38/16 (2006.01) , A61K 47/16 (2006.01) , A61K 47/22 (2006.01) , A61K 47/36 (2006.01) , A61K 47/42 (2006.01) | | Title | Lægemidler med botulinustoxin | | Int. application no. | US2001003641 | | Int. publication no. | WO2001058472 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
